Julie McElrath, HIV Vaccine Trials Unit contribute to research breakthrough that may explain how some HIV-positive people control the virus with immune system alone
Nov. 15, 2010
| By Kristen Woodward
An international research consortium involving Dr. Julie McElrath and other clinical researchers from the Seattle HIV Vaccine Trials Unit—a joint program of the Fred Hutchinson Cancer Research Center and the University of Washington—is a significant step closer to understanding the genetics of "elite controllers."
Michael Miyauchi Foundation funds annual science symposium for high schoolers from across the state
Nov. 8, 2010
| By Christi Ball Loso
Hutch High science symposium attendees traveled to the Fred Hutchinson Cancer Research Center from 27 schools to attend a program that offers hands-on laboratory experiences along with valuable information about pursuing a career in science.
Mothers nearly 40 percent less likely to have the disease
April 12, 2010
| By Colleen Steelquist
A new study by Fred Hutchinson Cancer Research Center scientists finds that women who give birth may have a lower risk of developing rheumatoid arthritis than women who remain childless, but the potential protective effect seems to fade over the years.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.